AI & ChatGPT searches , social queries for ALACIZUMAB PEGOL

Search references for ALACIZUMAB PEGOL. Phrases containing ALACIZUMAB PEGOL

See searches and references containing ALACIZUMAB PEGOL!

AI searches containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

  • Alacizumab pegol

    • Pharmaceutical drug

    Alacizumab pegol is an antineoplastic agent. Chemically, it is a pegylated F(ab')2 fragment of a monoclonal antibody. International Nonproprietary Names

    Alacizumab pegol

    Alacizumab_pegol

  • Pegol

    • Class of pharmaceutical compounds

    of the drug. Examples include: Alacizumab pegol Calaspargase pegol Certolizumab pegol Etirinotecan pegol Lulizumab pegol Swierczewska, Magdalena; Lee,

    Pegol

    Pegol

  • Bevacizumab

    • Medication

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Bevacizumab

    Bevacizumab

  • Evolocumab

    • Pharmaceutical drug

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Evolocumab

    Evolocumab

  • Denosumab

    • Human monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Denosumab

    Denosumab

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Testosterone

    • Primary male sex hormone

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Testosterone

    Testosterone

    Testosterone

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Lecanemab

    Lecanemab

  • List of therapeutic monoclonal antibodies

    • IL-17A, IL-17F multiple sclerosis Afelimomab F(ab')2 mouse TNF-α sepsis Alacizumab pegol F(ab')2 humanized VEGFR2 cancer Alemtuzumab Lemtrada, Campath mab humanized

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Bedinvetmab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • Alirocumab

    • Pharmaceutical drug

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Alirocumab

    Alirocumab

  • Donanemab

    • Monoclonal antibody against amyloid beta

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Donanemab

    Donanemab

  • Anti-amyloid antibodies

    • Drug class

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Ranibizumab

    • Pharmaceutical drug

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Ranibizumab

    Ranibizumab

  • Galcanezumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Cetuximab

    • Pharmaceutical drug

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Cetuximab

    Cetuximab

    Cetuximab

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Fremanezumab

    Fremanezumab

  • Erenumab

    • Chemical compound

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Erenumab

    Erenumab

    Erenumab

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Trastuzumab

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Filgrastim

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Filgrastim

    Filgrastim

    Filgrastim

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Growth factor

    Growth_factor

  • Trastuzumab deruxtecan

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Rinucumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Rinucumab

    Rinucumab

  • Pegfilgrastim

    • Monoclonal antibody

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Pegfilgrastim

    Pegfilgrastim

  • Dasatinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Dasatinib

    Dasatinib

    Dasatinib

  • Abciximab

    • Pharmaceutical compound

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Abciximab

    Abciximab

    Abciximab

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Cerebrolysin

    Cerebrolysin

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Aducanumab

    Aducanumab

  • Trastuzumab emtansine

    • Pharmaceutical drug

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trastuzumab emtansine

    Trastuzumab emtansine

    Trastuzumab_emtansine

  • Amitriptyline

    • Tricyclic antidepressant

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Fibroblast growth factor 2

    • Growth factor and signaling protein otherwise known as FGF2

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Fibroblast growth factor 2

    Fibroblast growth factor 2

    Fibroblast_growth_factor_2

  • Pazopanib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Pazopanib

    Pazopanib

  • Insulin

    • Peptide hormone

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Insulin

    Insulin

    Insulin

  • Humanized antibody

    • Antibodies from non-human species made nearly identical to human ones

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Humanized antibody

    Humanized_antibody

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Osimertinib

    Osimertinib

    Osimertinib

  • Fibroblast growth factor receptor

    • Family of proteins that bind to fibroblast growth factors

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Fibroblast growth factor receptor

    Fibroblast_growth_factor_receptor

  • Ramucirumab

    • Pharmaceutical drug

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Ramucirumab

    Ramucirumab

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Trametinib

    • Anticancer medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trametinib

    Trametinib

    Trametinib

  • Platelet-derived growth factor receptor

    • Cell surface receptors

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Platelet-derived growth factor receptor

    Platelet-derived growth factor receptor

    Platelet-derived_growth_factor_receptor

  • Hepatocyte growth factor

    • Mammalian protein found in Homo sapiens

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Integrin

    Integrin

    Integrin

  • Tyrosine kinase

    • Enzyme

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Idarucizumab

    • Medication

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Idarucizumab

    Idarucizumab

  • Trk receptor

    • InterPro Family

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trk receptor

    Trk_receptor

  • Evinacumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Evinacumab

    Evinacumab

  • Fruquintinib

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Fruquintinib

    Fruquintinib

    Fruquintinib

  • GFRA4

    • Protein-coding gene in the species Homo sapiens

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    GFRA4

    GFRA4

    GFRA4

  • Brigatinib

    • ALK inhibitor for treatment of non-small-cell lung cancer

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Brigatinib

    Brigatinib

    Brigatinib

  • Epidermal growth factor

    • Protein that stimulates cell division and differentiation

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Epidermal growth factor

    Epidermal growth factor

    Epidermal_growth_factor

  • IGF-1 LR3

    • Synthetic protein

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    IGF-1 LR3

    IGF-1_LR3

  • ACD856

    • TrkA and TrkB positive modulator

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    ACD856

    ACD856

  • Epidermal growth factor receptor

    • Transmembrane protein

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Neurotrophic factors

    • Family of biomolecules

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Neurotrophic factors

    Neurotrophic_factors

  • Lenvatinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Emicizumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Emicizumab

    Emicizumab

    Emicizumab

  • Neuregulin

    • Family of four EGF proteins

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Neuregulin

    Neuregulin

    Neuregulin

  • Regorafenib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Regorafenib

    Regorafenib

  • Afatinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Afatinib

    Afatinib

    Afatinib

  • Semaxanib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Semaxanib

    Semaxanib

    Semaxanib

  • Abelacimab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Abelacimab

    Abelacimab

  • Larotrectinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Larotrectinib

    Larotrectinib

    Larotrectinib

  • Ponatinib

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Ponatinib

    Ponatinib

    Ponatinib

  • Transforming growth factor

    • Biomarker indicative of breast cancer patients' prognosis

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Transforming growth factor

    Transforming_growth_factor

  • Lorlatinib

    • Kinase inhibitor for treatment of non-small-cell lung cancer

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Lorlatinib

    Lorlatinib

    Lorlatinib

  • Axitinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Axitinib

    Axitinib

    Axitinib

  • Tepotinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Tepotinib

    Tepotinib

    Tepotinib

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Burosumab

    Burosumab

  • Refanezumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Refanezumab

    Refanezumab

  • Erlotinib

    • Medication for treatment of non-small-cell lung cancer

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Erlotinib

    Erlotinib

    Erlotinib

  • Pertuzumab

    • Pharmaceutical drug

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Pertuzumab

    Pertuzumab

    Pertuzumab

  • Bimagrumab

    • Chemical compound

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Bimagrumab

    Bimagrumab

  • Avapritinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Avapritinib

    Avapritinib

    Avapritinib

  • Nomenclature of monoclonal antibodies

    • Naming scheme for assigning generic, or nonproprietary, names to monoclonal antibodies

    and to decrease its immunogenicity; this is shown by the word pegol as in alacizumab pegol. A cytotoxic agent can be linked to an anti-tumor antibody for

    Nomenclature of monoclonal antibodies

    Nomenclature_of_monoclonal_antibodies

  • Fibroblast growth factor 23

    • Protein found in humans

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Fibroblast growth factor 23

    Fibroblast growth factor 23

    Fibroblast_growth_factor_23

  • Relfovetmab

    • Veterinary medication

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Relfovetmab

    Relfovetmab

  • Trevogrumab

    • Monoclonal antibody

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Trevogrumab

    Trevogrumab

  • Panitumumab

    • Pharmaceutical drug

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Panitumumab

    Panitumumab

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • GFRA1

    • Protein-coding gene in the species Homo sapiens

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    GFRA1

    GFRA1

    GFRA1

  • Fibroblast growth factor receptor 3

    • Gene involved in the most common form of dwarfism

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Fibroblast growth factor receptor 3

    Fibroblast growth factor receptor 3

    Fibroblast_growth_factor_receptor_3

  • Blosozumab

    • Chemical compound

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Blosozumab

    Blosozumab

  • R13 (drug)

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    R13 (drug)

    R13 (drug)

    R13_(drug)

  • Pegaptanib

    • Drug to treat macular degeneration

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Pegaptanib

    Pegaptanib

    Pegaptanib

  • Neratinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Neratinib

    Neratinib

    Neratinib

  • Faricimab

    • Medication for macular degeneration

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Faricimab

    Faricimab

    Faricimab

  • Trofinetide

    • Pharmaceutical drug

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Trofinetide

    Trofinetide

    Trofinetide

  • FGF7

    • Protein-coding gene in the species Homo sapiens

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    FGF7

    FGF7

    FGF7

  • HER2

    • Mammalian protein found in humans

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    HER2

    HER2

    HER2

  • Artemin

    • Protein found in humans

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Artemin

    Artemin

    Artemin

  • Ripretinib

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Ripretinib

    Ripretinib

    Ripretinib

  • Amivantamab

    • Monoclonal antibody

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Amivantamab

    Amivantamab

    Amivantamab

  • Dihexa

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Dihexa

    Dihexa

    Dihexa

  • Infigratinib

    • Medication

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Infigratinib

    Infigratinib

  • Ponazuril

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Ponazuril

    Ponazuril

    Ponazuril

  • Eutropoflavin

    • Chemical compound

    Sorafenib Sunitinib Toceranib Tivozanib Vandetanib WHI-P 154 Antibodies: Alacizumab pegol Bevacizumab Icrucumab Ramucirumab Ranibizumab Decoy receptors: Aflibercept

    Eutropoflavin

    Eutropoflavin

    Eutropoflavin

  • Romosozumab

    • Pharmaceutical drug

    Mouse Biciromab‡ Imciromab‡ Chimeric Abciximab Volociximab Humanized Alacizumab pegol Bevacizumab/Ranibizumab Bococizumab Brolucizumab Caplacizumab Concizumab

    Romosozumab

    Romosozumab

AI & ChatGPT searchs for online references containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

AI search references containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

AI search queries for Facebook and twitter posts, hashtags with ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

Follow users with usernames @ALACIZUMAB PEGOL or posting hashtags containing #ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

AI searchs for Acronyms & meanings containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL

AI searches, Indeed job searches and job offers containing ALACIZUMAB PEGOL

Other words and meanings similar to

ALACIZUMAB PEGOL

AI search in online dictionary sources & meanings containing ALACIZUMAB PEGOL

ALACIZUMAB PEGOL